Table 1

Baseline demographic and clinical characteristics of subjects

CharacteristicsNo (n=394 026)%
Gender
 Female242 11561.4
 Male151 86638.6
 Missing data (n=45)
Age group (years)
 40–4449 28112.9
 45–4971 56418.7
 50–5478 42820.5
 55–5969 53018.2
 ≥60 years114 30529.8
 Mean±SD54.92±9.03
 Median (minimum:maximum)54 (40:100)
 Missing data (n=10 918)
Education levels
 None65611.7
 Primary286 84072.9
 Secondary78 09019.9
 Certificate/bachelor18 6324.7
 Higher than bachelor30550.8
  Missing data (n=848)
Occupation
 Unemployed15 5824.0
 Farmer306 42177.9
 Labour32 4208.2
 Own business13 4673.4
 Government official/state enterprises13 9973.6
 Others11 3352.9
 Missing data (n=804)
Relatives diagnosed with CCA
 No319 90281.4
 Yes73 28618.6
 Missing data (n=838)
Liver fluke infection
 No113 17862.1
 Yes68 97937.9
 Missing data (n=211 869)
Praziquantel treatment
 None270 18370.3
 One time84 13621.9
 Two times18 1264.7
 Three times52641.4
 More than three times64141.7
 Missing data (n=9903)
Smoking history
 No308 77678.7
 Yes, current or previous83 75421.3
 Missing data (n=1496)
Alcohol consumption history
 No214 49554.6
 Yes, current or previous178 56445.4
 Missing data (n=967)
Hepatitis B
 No382 05898.2
 Yes68031.8
 Missing data (n=5165)
Hepatitis C
 No388 11499.8
 Yes7470.2
 Missing data (n=5165)
Diabetes mellitus
 No362 29693.2
 Yes26 5656.8
 Missing data (n=5165)
Periductal fibrosis
 None324 48282.4
 PDF148 38312.3
 PDF218 6864.7
 PDF324750.6
  • CCA, cholangiocarcinoma; PDF, periductal fibrosis.